UBS Group’s Corteva CTVA Stock Holding History

UBS Group’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$339K	Buy	+4,000	New	+$321K	﹤0.01%	6470
2025 Q4	–	Sell	-10,000	Closed	-$676K	–	10601
2025 Q3	$676K	Buy	+10,000	New	+$725K	﹤0.01%	5871
2024 Q2	–	Sell	-50,000	Closed	-$2.88M	–	9602
2024 Q1	$2.88M	Buy	+50,000	New	+$2.58M	﹤0.01%	3569
2021 Q2	–	Sell	-11,600	Closed	-$541K	–	9434
2021 Q1	$541K	Buy	+11,600	New	+$513K	﹤0.01%	4802
2020 Q4	–	Sell	-686	Closed	-$20K	–	8437
2020 Q3	$20K	Buy	+686	New	+$19.3K	﹤0.01%	6299
2020 Q1	–	Sell	-1,678,000	Closed	-$49.6M	–	8019
2019 Q4	$49.6M	Buy	1,678,000 +1,613,600	+2,506%	+$42.7M	0.02%	780
2019 Q3	$1.8M	Buy	+64,400	New	+$1.86M	﹤0.01%	3396

Other funds holding CTVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

UBS Group's CTVA Position: Q2 2026 in Review

UBS Group reduced its Corteva (CTVA) stake by 1.3% in Q2 2026, selling an estimated $2.93M and leaving 2,861,946 shares worth $242M. The position accounts for 0.03% of the portfolio, ranked #563.

UBS Group first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $243M in Q1 2026. 1,494 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

UBS Group held 2,861,946 shares of Corteva worth $242M as of Q2 2026.
UBS Group sold 36,472 Corteva shares in Q2 2026, an estimated $2.93M.
Corteva made up 0.03% of UBS Group's portfolio in Q2 2026, its #563 holding.
UBS Group first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
UBS Group's Corteva position peaked at $243M in Q1 2026.
1,494 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.